Atopic Dermatitis Clinical Trials in North Little Rock, Arkansas

3 studies are recruiting for atopic dermatitis in North Little Rock, Arkansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

    This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in children 2 years of age or older with moderate-to-severe atopic dermatitis. The study will enroll two groups: participants who have completed other abrociti…

    Stage
    Phase 3
    Ages
    2 to 11
    Site
    Arkansas Research Trials, North Little Rock, Arkansas
    Locations
    41 in total
    Run by
    Pfizer

    See if you can join NCT06807281 on ClinicalTrials.gov

  2. A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

    The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections [SC]) in combination with topical corticosteroids (TCS) is safe and effective to treat moderate-to-severe atopic dermatitis (AD) in children and infants. This will be judged by a range of …

    Stage
    Phase 3
    Ages
    0 to 11
    Site
    Leo Pharma Investigational site, North Little Rock, Arkansas
    Locations
    72 in total
    Run by
    LEO Pharma

    See if you can join NCT06311682 on ClinicalTrials.gov

  3. A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

    The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of a single and multiple SC dose of BxC-I17e in patients with moderate to severe atopic dermatitis (AD)

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Arkansas Research Trials, North Little Rock, Arkansas
    Locations
    3 in total
    Run by
    Brexogen Inc.

    See if you can join NCT06055361 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.